Effect of some acute and prophylactic antimigraine drugs on the vasodepressor sensory CGRPergic outflow in pithed rats

Life Sciences

Volumn 84, Issue 5-6, 2009, Pages 125-131

  Lozano Cuenca, Jair ^a   González Hernández, Abimael ^a   Muñoz Islas, Enriqueta ^a   Sánchez López, Araceli ^a   Centurión, David ^a   Cobos Puc, Luis E ^a   Villalón, Carlos M ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

CGRP; Dihydroergotamine; Ergotamine; Magnesium valproate; Pithed rat; Propranolol; Sumatriptan; Vasodepressor sensory outflow

Indexed keywords

ANTIMIGRAINE AGENT; CALCITONIN GENE RELATED PEPTIDE; DIHYDROERGOTAMINE; ERGOTAMINE; PROPRANOLOL; SUMATRIPTAN; VALPROATE MAGNESIUM;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR SYSTEM; CONTINUOUS INFUSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROSTIMULATION; HEART HEMODYNAMICS; HEART RATE; MALE; NONHUMAN; PRESSOR RESPONSE; RAT; SPINAL CORD;

ANALGESICS; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CARDIOVASCULAR SYSTEM; DECEREBRATE STATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HEMODYNAMICS; MALE; MIGRAINE DISORDERS; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; VASOMOTOR SYSTEM;

ANIMALIA; RATTUS;

EID: 58249084562     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.11.008     Document Type: Article

References (40)

1. Arulmozhi D.K., Veeranjaneyulu A., and Bodhankar S.L. Migraine: current therapeutic targets and future avenues. Current Vascular Pharmacology 4 2 (2006) 117-128
2. Boehm S., and Kubista H. Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacological Reviews 54 1 (2002) 43-99
3. Brain S.D., Williams T.J., Tippins J.R., Morris H.R., and MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 313 5997 (1985) 54-56
4. Buxton I.L.O. Pharmacokinetics and pharmacodynamics: the dynamics of drug absorption, distribution, action, and elimination. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. eleventh ed. (2006), McGraw-Hill, New York 1-39
5. Buzzi M.G., Carter W.B., Shimizu T., Heath III H., and Moskowitz M.A. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30 11 (1991) 1193-1200
6. 1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin. Pain 134 1-2 (2008) 97-105
7. Cutrer F.M., Limmroth V., Ayata G., and Moskowitz M.A. Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. British Journal of Pharmacology 116 8 (1995) 3199-3204
8. 1D (BRL15572) receptor antagonists. European Journal of Pharmacology 362 1 (1998) 69-72
9. 2 subtypes in rat vasculature in vitro and in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 326 1 (1984) 1-6
10. Diener H.C. Pharmacological approaches to migraine. Journal of Neural Transmission. Supplementum 64 (2003) 35-63
11. Gillespie J.S., MacLaren A., and Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. British Journal of Pharmacology 40 2 (1970) 257-267
12. Gupta S., Akerman S., van den Maagdenberg A.M., Saxena P.R., Goadsby P.J., and van den Brink A.M. Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine. Cephalalgia 26 11 (2006) 1294-1303
13. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 6852 (2001) 203-210
14. Kawasaki H., Takasaki K., Saito A., and Goto K. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335 6186 (1988) 164-167
15. Kleinman L.I., and Radford E.P. Ventilation standards for small mammals. Journal of Applied Physiology 19 (1964) 360-362
16. A receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation. British Journal of Pharmacology 116 1 (1995) 1661-1667
17. Limmroth V., Katsarava Z., Liedert B., Guehring H., Schmitz K., Diener H.C., and Michel M.C. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain 92 1-2 (2001) 101-106
18. Markowitz S., Saito K., and Moskowitz M.A. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 8 2 (1988) 83-91
19. 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats. Archives Internationales de Pharmacodynamie et de Therapie 284 1 (1986) 30-37
20. Saito K., Markowitz S., and Moskowitz M.A. Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Annals of Neurology 24 6 (1988) 732-737
21. 5A/5B receptors. British Journal of Pharmacology 140 4 (2003) 725-735
22. 1D subtypes. Naunyn-Schmiedeberg's Archives of Pharmacology 369 2 (2004) 220-227
23. Sørensen K.V. Valproate: a new drug in migraine prophylaxis. Acta Neurologica Scandinavica 78 4 (1988) 346-348
24. Steel R.G.D., and Torrie J.H. Principles and Procedures of Statistics: A Biomedical Approach. second ed. (1980), McGraw-Hill, New York
25. Suzuki N., Hardebo J.E., and Owman C. Origins and pathways of cerebrovascular nerves storing substance P and calcitonin gene-related peptide in rat. Neuroscience 31 2 (1989) 427-438
26. Taguchi T., Kawasaki H., Imamura T., and Takasaki K. Capsaicin-sensitive nonadrenergic and noncholinergic depressor response to spinal cord stimulation in the pithed rat. Brain Research 572 1-2 (1992) 352-355
27. Taguchi T., Kawasaki H., Imamura T., and Takasaki K. Endogenous calcitonin gene-related peptide mediates nonadrenergic noncholinergic depressor response to spinal cord stimulation in the pithed rat. Circulation Research 71 2 (1992) 357-364
28. 1-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomized dogs. Naunyn-Schmiedeberg's Archives of Pharmacology 370 1 (2004) 46-53
29. Van Rossum D., Hanisch U.K., and Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neuroscience & Biobehavioral Reviews 21 5 (1997) 649-678
30. Vanmolkot F.H., and de Hoon J.N. Acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform. Clinical Pharmacology and Therapeutics 80 1 (2006) 85-94
31. Villalón C.M., and Centurión D. Cardiovascular responses produced by 5-hydroxytryptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications. Naunyn-Schmiedeberg's Archives of Pharmacology 376 1-2 (2007) 45-63
32. 1D subtypes. British Journal of Pharmacology 124 5 (1998) 1001-1011
33. Villalón C.M., Centurión D., Valdivia L.F., de Vries P., and Saxena P.R. Migraine: an updated review on pathophysiology, pharmacology, therapy and future trends. Current Vascular Pharmacology 1 1 (2003) 71-84
34. 2A/2C-adrenoceptors mediate external carotid vasoconstriction to dihydroergotamine. European Journal of Pharmacology 484 2-3 (2004) 287-290
35. 2A/2C-adrenoceptors. British Journal of Pharmacology 154 1 (2008) 51-59
36. Westfall T.C., and Westfall D.P. Neurotransmission: The autonomic and somatic motor nervous systems. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. eleventh ed. (2006), McGraw-Hill, New York 137-181
37. Westfall T.C., and Westfall D.P. Adrenergic agonists and antagonists. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. eleventh ed. (2006), McGraw-Hill, New York 237-295
38. Willems E.W., Valdivia L.F., Villalón C.M., and Saxena P.R. Possible role of α-adrenoceptor subtypes in acute migraine therapy. Cephalalgia 23 4 (2003) 245-257
39. Williamson D.J., Hargreaves R.J., Hill R.G., and Shepheard S.L. Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat-intravital microscope studies. Cephalalgia 17 4 (1997) 525-531
40. Wimalawansa S.J. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocrine Reviews 17 5 (1996) 533-585